Angiogen, Inc.

Company Information

Company Name
Angiogen, Inc.
Address
Angiogen, Inc.
4050 Sorrento Valley Blvd, Ste O
San Diego, CA, 92121 0142
Phone
1 858-457-3707
URL
n/a
DUNS
n/a
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$200,000.00
4
STTR Phase I
$135,887.00
1
Chart code to be here

Award List

  1. VASCULARIZATION OF MANY SOLID TUMORS OCCURS IN VIVO AS A CONSEQUENCE OF THE VECTORIAL GROWTH OF HOST CAPILLARY ENDOTHELIAL CELLS ALONG A CONCENTRATION GRADIENT OF TUMOR- PRODUCED, DIFFUSIBLE ANGIOGENESIS FACTOR(S).

    Amount: $50,000.00

    VASCULARIZATION OF MANY SOLID TUMORS OCCURS IN VIVO AS A CONSEQUENCE OF THE VECTORIAL GROWTH OF HOST CAPILLARY ENDOTHELIAL CELLS ALONG A CONCENTRATION GRADIENT OF TUMOR- PRODUCED, DIFFUSIBLE ANGIOGENE ...

    SBIR Phase I 1986 Department of Health and Human Services
  2. THE PROPOSED STUDY TARGETS THE WELL-VASCULARIZED AND REFRACTORY CLASS OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS FOR THE DEVELOPMENT OF NOVEL METHODS FOR DETECTING THE PRESENCE AND QUANTITATING AMOUNTS OF SPECIFIC TUMOR-PRODUCED ANGIO- GENESIS FACTORS (AF).

    Amount: $50,000.00

    THE PROPOSED STUDY TARGETS THE WELL-VASCULARIZED AND REFRACTORY CLASS OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS FOR THE DEVELOPMENT OF NOVEL METHODS FOR DETECTING THE PRESENCE AND QUANTITATING AMOUNTS OF ...

    SBIR Phase I 1986 Department of Health and Human Services
  3. RETINOPATHY TREATMENT: HEPARIN-TARGETED ANTIANGIOGENESIS

    Amount: $50,000.00

    PROLIFERATIVE RETINOPATHY, OR OCULAR DISORDERS CHARACTERIZED BY ABNORMAL RETINAL NEOVASCULARIZATION, PRESENTS A SERIOUS CHALLENGE IN OPHTHALMOLOGY. CONVENTIONALTREATMENTS-LASER PHOTOCOAGULATION AND VI ...

    SBIR Phase I 1987 Department of Health and Human Services
  4. EFFECTS OF ANGIOGENESIS FACTORS ON SKIN FLAP SURVIVAL

    Amount: $50,000.00

    IN SPITE OF THE COMMON USE OF SKIN GRAFTS AND SKIN FLAPS IN PLASTIC AND RECONSTRUCTIVE SURGERY, SERIOUS COMPLICATIONS STILL ARISE. THE COMPLETE OR PARTIAL NECROSIS THAT CAN OCCUR IN SURGICAL FLAPS OR ...

    SBIR Phase I 1989 Department of Health and Human Services
  5. Histone Deacetylase Inhibitors for Cancer Treatment

    Amount: $135,887.00

    DESCRIPTION (provided by applicant): Histone deacetylases (HDACs) comprise a family of enzymes that catalyze the removal of acetyl groups from lysine residues of histones. They mediate chromatin remod ...

    STTR Phase I 2005 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government